Received Apr 17, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEPA | HEP A (VAQTA) | MERCK & CO. INC. | 2 | Z006736 | IM / RL |
Pt father states that starting Thursday night 04/16/2026 the Pt began experiencing a fever that lasted into Friday 04/17/2026. Pt father stated that the Pt fever at 3:14P was 102.6°F, stated that the Pt is grasping at her R leg (site of the immunization) between the knee and toes (lower leg) saying, "ouchy, ouchy". Additionally, the Pt father stated that the Pt seems lethargic and has had some loss of appetite today 04/17/2026. Pt dad denied redness, swelling, or red streaking at or near the injection site, denies dizziness, altered mental status or SOB/difficulty breathing. Pt dad confirmed that there was no reaction with the 1st dose of Hep A given on 07/16/2025. Pt dad stated that APAP had not yet been administered as of 3:14P. Per clinic provider, it was recommended to have Pt parents administer APAP and CTM for changing or worsening Sx. Worsening Sx were discussed with the Pt father and UC/ED protocol was reviewed. Outreach was made to the Pt father at 6:19P to follow-up on the Pt Sx. Pt dad who states that the Pt fever did go down with APAP, but that the Pt is still quite fussy, irritable and complaining of the pain to the R leg. Pt father stated that the Pt is eating, drinking and urinating well. Spoke to the Pt dad who stated that the Pt fever did go down with APAP, but that the Pt is still quite fussy, irritable and complaining of the pain to the R leg. Again, Pt father denied N/V, swelling redness or red streaking at the or near the injection site. Per clinic provider, it was recommended to CTM and Tx with APAP PRN, but to present to UC/ED with any worsening Sx. Again, Pt father was informed of worsening Sx and ED/UC protocol.